Type I IFN immunoprofiling in COVID-19 patients - 22/07/20
Doi : 10.1016/j.jaci.2020.04.029
Sophie Trouillet-Assant, PhD a, b, ∗ 
, Sebastien Viel, PharmD, PhD b, c, d, e, ∗, Alexandre Gaymard, PharmD, PhD b, f, ∗ , Sylvie Pons, MS a, Jean-Christophe Richard, MD, PhD g, h, Magali Perret, MS b, c, Marine Villard, PhD b, c, Karen Brengel-Pesce, PhD a, Bruno Lina, MD, PhD b, f, Mehdi Mezidi, MD g, h, Laurent Bitker, MD g, h, Alexandre Belot, MD, PhD b, d, e, i
for
, Sebastien Viel, PharmD, PhD b, c, d, e, ∗, Alexandre Gaymard, PharmD, PhD b, f, ∗ , Sylvie Pons, MS a, Jean-Christophe Richard, MD, PhD g, h, Magali Perret, MS b, c, Marine Villard, PhD b, c, Karen Brengel-Pesce, PhD a, Bruno Lina, MD, PhD b, f, Mehdi Mezidi, MD g, h, Laurent Bitker, MD g, h, Alexandre Belot, MD, PhD b, d, e, ifor
COVID HCL Study group‡
William Mouton, Guy Oriol, Christelle Compagnon, Laurence Generenaz, Valérie Cheynet, Florence Ader, Agathe Becker, Nicholas Benech, Pierre Chauvelot, Christian Chidiac, Anne Conrad, Tristan Ferry, Patrick Miailhes, Thomas Perpoint, Marielle Perry, Cécile Pouderoux, Sandrine Roux, Claire Triffault-Fillit, Florent Valour, Yonis Hodane, Louis Chauvelot, Paul Chabert, Judith Provoost, Guillaume David, Laure Folliet, Pierre Lecam, Geneviève Billaud, Maude Bouscambert, Vanessa Escuret, Emilie Frobert, Antonin Bal, Grégory Destras, Laurence Josset, Florence Morfin, Clément Munier, Martine Valette, Fabienne Venet, Lorna Garnier, Rémi Pescarmona, Christine Lombard, Thierry Walzer
a Joint Research Unit, Hospices Civils de Lyon-bioMérieux, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France
b International Center of Research in Infectiology, Lyon University, INSERM U1111, CNRS UMR 5308, ENS, UCBL, Lyon, France
c Immunology Laboratory, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France
d National Referee Centre for Rheumatic and AutoImmune and Systemic diseases in childrEn (RAISE), Lyon, France
e Lyon Immunopathology Federation LIFE, Hospices Civils de Lyon, Lyon, France
f Virology Department, Infective Agents Institute, National Reference Center for Respiratory Viruses, North Hospital Network, Lyon, France
g Lyon University, CREATIS, CNRS UMR5220, Inserm U1044, INSA, Lyon, France
h Intensive Care Unit, Hospices Civils de Lyon, Lyon, France
i Pediatric Nephrology, Rheumatology, Dermatology Unit, Hospices Civils de Lyon, Lyon, France
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
| Quanterix and Nanostring provided the kits for this study free of charge. |
|
| Disclosure of potential conflict of interest: S. Pons, G. Oriol, K. Brengel-Pesce, W. Mouton, and C. Compagnon are Biomérieux employees. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2020
Pubblicato da Elsevier Masson SAS.
Vol 146 - N° 1
P. 206 - Luglio 2020 Ritorno al numero
Articolo precedente
- Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2
- Daniel J. Jackson, William W. Busse, Leonard B. Bacharier, Meyer Kattan, George T. O’Connor, Robert A. Wood, Cynthia M. Visness, Stephen R. Durham, David Larson, Stephane Esnault, Carole Ober, Peter J. Gergen, Patrice Becker, Alkis Togias, James E. Gern, Mathew C. Altman
- ACE2, TMPRSS2, and furin gene expression in the airways of people with asthma—implications for COVID-19
- Peter Bradding, Matthew Richardson, Timothy S.C. Hinks, Peter H. Howarth, David F. Choy, Joseph R. Arron, Sally E. Wenzel, Salman Siddiqui
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.